ILC Therapeutics

About:

ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.

Website: https://www.ilctherapeutics.com/

Top Investors: Scottish Enterprise, Medical Incubator Japan, EOS Technology Investment Syndicate, Robert Kopple

Description:

ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.

Total Funding Amount:

6M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newhouse, North Lanarkshire, United Kingdom

Founded Date:

2012-01-01

Contact Email:

contact(AT)ilctherapeutics.com

Founders:

Alistair Strachan, William Stimson

Number of Employees:

1-10

Last Funding Date:

2024-09-11

IPO Status:

Private

Industries: